Skip to main content
Premium Trial:

Request an Annual Quote

Virus as Good Guy

Premium

At The New York Times' In Theory column, Rachel Nuwer puts forth the hypothesis that viruses can be used to attack tumors. Nuwer speaks to Harvard Medical School's Robert Martuza, Bernard Roizman of the University of Chicago, and New York University's Ian Mohr who tells her that the effect of viruses on cancer cells has been known since the 1990s when doctors noticed that cancer patients who contracted a viral infection often had short reprieves from their cancers. "It was not a coincidence," Nuwer says. "Common viruses sometimes attack tumor cells, researchers discovered. For decades, they tried to harness this phenomenon, to transform it into a cancer treatment. Now, after a long string of failures, they are nearing success with viruses engineered to kill cancer."

Harvard's Martuza notes that there are already several advanced trials for cancer drugs that are made from engineered viruses. A form of vaccinia, the agent that vaccinated against smallpox, is being tested in the treatment of liver cancer, and a herpes virus based on work done by NYU's Mohr is being tested against melanoma. "Unlike chemotherapy, which can diminish in effectiveness over time, oncolytic viruses multiply in the body and gain strength as the infection becomes established," Nuwer says. "In addition to attacking cancer cells directly, some also produce an immune response that targets tumors."

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.